Navigation Links
Pandemic vaccination did not increase risk of fetal death
Date:1/17/2013

With the rapid progression of molecular biology and genetics, and the subsequent emergence of many new targets, emerging targets & therapeutics provides new opportunities for the prevention and treatment of several major disease systems. The 4th Cancer Targets & Therapeutics Conference, taking place on February 25-26, 2013 in Las Vegas, NV will continue to be a premier event for translational researchers, preclinical scientists and managers, and those carrying out early phase clinical trials, working to identify and exploit advances in the field in order to deliver products with a meaningful clinical impact. Both cutting-edge researchers and those who guide its commercial development will be on-hand to share their knowledge and insights as to how therapeutic cancer targets are identified, and how this research translates into meaningful therapeutics that benefit patients living with cancer.

Attendees will learn about:

  • Important progress in key aspects of antibody, vaccine, and cell-based therapies being developed and evaluated in clinical trials for the immunotherapy of cancer

  • How cellular pathways of protein processing and pivotal cell-death pathways are being targeted by new Therapies New therapeutic targets in epigenetic and newly described metabolic pathways that serve as new pathways for drug discovery

  • Advances in targeting angiogenesis

  • Important new animal models for target validation

  • New approaches to drug-conjugates and to dose evaluation for effective therapy

Preliminary Sessions for 2013 Agenda:

  • Novel Kinase Inhibitors & Beyond the Kinome

  • Functional Genomics & Future Cancer targets

  • Novel Antibody-based Modalities

  • Progress in Cancer Immunotherapy

  • Cancer Stem Cells, Metabolism, Cancer Epigenetics

  • Novel Advances & Technologies in Oncology


'/>"/>

Contact: Press Officer
47-210-78300
Norwegian Institute of Public Health
Source:Eurekalert

Page: 1

Related biology news :

1. Improving equine health: Research studies vaccinations to protect newborn foals
2. The effect of treatment with antibiotics and vaccination against Q fever in sheep
3. Teens susceptible to hepatitis B infection despite vaccination as infants
4. Increase in Arctic shipping poses risk to marine mammals
5. Columbia Engineering and Penn researchers increase speed of single-molecule measurements
6. Fertilizer use responsible for increase in nitrous oxide in atmosphere
7. NIST/UMass study finds evidence nanoparticles may increase plant DNA damage
8. Study finds soda consumption increases overall stroke risk
9. Scientists have discovered genes that increase the risk of osteoporosis and fractures
10. Family history of liver cancer increases risk of developing the disease
11. Research shows how PCBs promote dendrite growth, may increase autism risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/15/2016)... ALBANY, New York , June 15, 2016 ... published a new market report titled "Gesture Recognition Market ... Trends and Forecast, 2016 - 2024". According to the ... at USD 11.60 billion in 2015 and is ... and reach USD 48.56 billion by 2024.  ...
(Date:6/9/2016)... Finland , June 9, 2016 ... National Police deploy Teleste,s video security solution to ensure the ... France during the major tournament ... data communications systems and services, announced today that its video ... Prefecture to back up public safety across the ...
(Date:6/3/2016)... , June 3, 2016 ... von Nepal hat ... Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung ... in der Produktion und Implementierung von Identitätsmanagementlösungen. ... Ausschreibung im Januar teilgenommen, aber Decatur wurde ...
Breaking Biology News(10 mins):
(Date:12/2/2016)... Raleigh, NC (PRWEB) , ... December 01, 2016 ... ... the US Computational Science Symposium (CSS) and the popularity of US Single Day ... will take place in early Summer 2018, in Raleigh, NC. Topics of the ...
(Date:12/2/2016)... ... December 01, 2016 , ... Orthogonal, a ... their recent FDA Class II 510(k) clearance for their flagship medical device, SimplECG. ... remote cardiac monitoring devices that rely on cloth-based nanosensors. While other companies have ...
(Date:12/2/2016)... NEW YORK , Dec. 1, 2016   ... liquid photopurification, announced today that the Company has concluded ... has the right for a 90-day period to acquire ... invoice value of approximately USD 3.7 million.  ... an agreement with Tamarack under which Tamarack will seek ...
(Date:11/30/2016)... CA (PRWEB) , ... November 30, 2016 , ... ... a new moving magnet Voice Coil Actuator with a flexure design that ensures ... long life with cost-effective pricing and is ideally suited where extreme precision is ...
Breaking Biology Technology: